A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Sponsor: Novartis Pharmaceuticals
Boston, MA · +8 more sites
14 recruiting sickle cell disease studies with a site in Boston, MA.
Sponsor: Novartis Pharmaceuticals
Boston, MA · +8 more sites
Sponsor: Novo Nordisk A/S
Boston, MA · +38 more sites
Sponsor: Novo Nordisk A/S
Boston, MA · +48 more sites
Sponsor: Bristol-Myers Squibb
Boston, MA · +17 more sites
Sponsor: American Thrombosis and Hemostasis Network
Boston, MA · +75 more sites
Sponsor: University of Rochester
Boston, MA · +29 more sites
Sponsor: Boston Children's Hospital
Boston, MA
Sponsor: Daniel Bauer
Boston, MA
Sponsor: Beam Therapeutics Inc.
Boston, MA · +16 more sites
Sponsor: Boston Children's Hospital
Boston, MA
Sponsor: Cyprus Institute of Neurology and Genetics
Boston, MA
Sponsor: Natasha Archer
Boston, MA
Sponsor: Massachusetts General Hospital
Boston, MA
Sponsor: Daniel Bauer
Boston, MA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.